[vc_row][vc_column][vc_separator css=”.vc_custom_1650304580539{padding-top: 20px !important;padding-bottom: 20px !important;}”][vc_separator css=”.vc_custom_1650304597437{padding-top: 20px !important;padding-bottom: 20px !important;}”][vc_separator css=”.vc_custom_1650304623745{padding-top: 20px !important;padding-bottom: 20px !important;}”][vc_row_inner][vc_column_inner width=”1/6″][vc_single_image image=”2203″ img_size=”full” alignment=”center”][/vc_column_inner][vc_column_inner width=”5/6″][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Olga Yanvoskaya | International Sales & Marketing
Former executive with Covidien/Medtronic.
[/mpc_icon_column][/vc_column_inner][/vc_row_inner][vc_separator css=”.vc_custom_1650304634897{padding-top: 20px !important;padding-bottom: 20px !important;}”][vc_row_inner][vc_column_inner width=”1/6″][vc_single_image image=”2539″ img_size=”full” alignment=”center” style=”vc_box_rounded”][/vc_column_inner][vc_column_inner width=”5/6″][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Glenn Brunner | Quality Assurance
President, CEO Medical Device Engineer of large to early-stage medical device companies Medex (Smiths Medical), Opticon Medical, (Bard BD), Wiseology LLC.
[/mpc_icon_column][/vc_column_inner][/vc_row_inner][vc_separator css=”.vc_custom_1650304645748{padding-top: 20px !important;padding-bottom: 20px !important;}”][/vc_column][/vc_row][vc_section][vc_row][vc_column][vc_custom_heading text=”Board of Directors” font_container=”tag:h2|font_size:48px|text_align:left|line_height:56px” google_fonts=”font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:100%20light%20regular%3A100%3Anormal”][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Jay Golding | Chairman
Founder, CEO Hi-Port Industries, Falcon Seaboard, Golding Brothers Partners. Director of Benchmark Hospitality and other private companies
[/mpc_icon_column][vc_separator][vc_separator][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
John P. Kennedy | Director
Founder of Kennedy Partners LLC, specializing in public-private partnerships. Former partner of Crabbe, Brown & James, former Court of Appeals Judge, Ohio, 10th District.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Peter Allen | Director
Industry veteran led Becton Dickinson IV catheter business, EVP for Vizient, the worlds largest GPO.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Raymond K. Houck | Director
Current CEO of Aclipse Therapeutics, Former CEO & Co-Founder of Thar Pharmaceuticals, Automated Cell and SuprexCorporation.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Henry Haimsohn | Director
Served in a number of positions at Handyman of California a subsidiary of Edison Brothers Stores. Founded the Pace Membership Warehouse as its Chairman and CEO.
[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Shawn Langer | Director
Brings over two decades of healthcare industry experience, and served as a Senior Partner at McKinsey & Company as the leader of its Healthcare Private Equity Group.[/mpc_icon_column][vc_separator][vc_custom_heading text=”Chief Advisors” font_container=”tag:h2|font_size:48px|text_align:left|line_height:56px” google_fonts=”font_family:Roboto%3A100%2C100italic%2C300%2C300italic%2Cregular%2Citalic%2C500%2C500italic%2C700%2C700italic%2C900%2C900italic|font_style:100%20light%20regular%3A100%3Anormal”][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Paul Savage, PhD | Science and Chemistry
Professor of Chemistry BYU, Inventor of Ceragenin class of compounds. Author of >175 peer reviewed journal articles.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Ronald Bracken | Coatings and Operations
Industry veteran, Former VP of R&D at CR Bard leading antimicrobial device coatings.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Michael Niederman | Critical Care Medicine
Associate Chief & Clinical Dir of Pulmonary and Critical Care Medicine at Weill Cornell. Wrote guidelines for treatment of Nosocomial Pneumonia.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
David Perlin, PhD | Medical Research
Highly accomplished medical researcher. Chief Scientific Officer and SVP for Hackensack Meridian Health Center for discover and innovation.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Jorge Hildago, M.D. | Critical Care Medicine
Professor of Critical Care at Karl Heuser Memorial in Belize. Secretary General of World Federation of Societies of Critical Care and Intensive Care Medicine.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Lisa Dwyer | Regulatory Strategy
Partner at King & Spalding. Specialization in FDA and Life Science. 20 years developing regulatory and legislative solutions.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Don Boyer | Canadian Regulatory
30 years experience as an expert regulatory consultant to the health products industry. Former head of Health Canada medical device department.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
John Doucet | Regulatory Strategy
Former US Food and Drug Administration (FDA) Policy Lead, for the Breakthrough Device Program.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Matthew Reed, PhD | Toxicology with Expertise in Cystic Fibrosis
Dr. Reed is a pharmacologist, board certified toxicologist, past ABT Board Member, and Fellow of the Academy of Toxicology Sciences (ATS). He has a close relationship with the Cystic Fibrosis Therapeutics Foundation.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Michelle Higgin, PhD | Program Leadership
Aggressive program management, preclinical pharmacology, nonclinical, regulatory, and early phase clinical trials. Michelle has opened 40+ INDs/IMPDs/CTAs/NDAs in US, Europe, and Australia.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Dale Christensen, PhD | Clinical Development
Experience managing pre-clinical discovery and pharmacology efforts across respiratory, inflammation, CNS, anti-infective, and oncology indications.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Tom Richardson, PhD | Science and Chemistry
Over 30 years of experience in formulation, drug delivery technologies and drug product manufacturing.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Jeffrey Wang, M.D. | Toxicology with Expertise in Cystic Fibrosis
Professor of Orthopedic Surgery and Neurosurgery at USC. Chief of USC Orthopedic Spine Services, Keck School of Medicine.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Michael John | Regulatory Strategy
Chief of the Interventional Cardiology Devices Branch in the Division of Cardiovascular Devices at the US Food and Drug Administration.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Georg Wieselthaler, M.D. | SBIR Consultant – Cardiology KOL
UCSF’s director and surgical chief of Cardiac Transplantation and Mechanical Circulatory Support.[/mpc_icon_column][vc_separator][mpc_icon_column layout=”style_3″ alignment=”left” border_divider=”true” padding_divider=”true” margin_divider=”true” title_font_color=”#222222″ title_font_size=”18″ title_font_line_height=”1″ title_font_transform=”uppercase” title_font_align=”center” title_margin_divider=”true” title_margin_css=”margin-top:0px;margin-bottom:0px;” content_font_color=”#666677″ content_font_size=”16″ content_font_line_height=”1.4″ content_font_transform=”none” content_font_align=”left” content_margin_divider=”true” hover_border_divider=”true” mpc_icon__disable=”true” mpc_icon__border_divider=”true” mpc_icon__padding_divider=”true” mpc_icon__margin_divider=”true” mpc_icon__hover_border_divider=”true” mpc_divider__disable=”true” mpc_divider__content_border_divider=”true” mpc_divider__content_padding_divider=”true” mpc_divider__padding_divider=”true” mpc_divider__margin_divider=”true” class=”n8-info-box” mpc_icon__mpc_tooltip__border_divider=”true” mpc_icon__mpc_tooltip__padding_divider=”true”]
Prabir Roy-Chaudhury, M.D. | SBIR Consultant – Kidney KOL
Professor of Medicine UNC Kidney Center, Division of Nephology and Hypertension. Main research in uremic vascular biology.[/mpc_icon_column][vc_separator][/vc_column][/vc_row][/vc_section]